A detailed history of Castleview Partners, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Castleview Partners, LLC holds 15,421 shares of BAX stock, worth $454,919. This represents 0.41% of its overall portfolio holdings.

Number of Shares
15,421
Previous 11,553 33.48%
Holding current value
$454,919
Previous $438,000 33.56%
% of portfolio
0.41%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$32.85 - $40.26 $127,063 - $155,725
3,868 Added 33.48%
15,421 $585,000
Q2 2024

Jul 31, 2024

BUY
$32.87 - $43.55 $236,499 - $313,342
7,195 Added 165.1%
11,553 $386,000
Q1 2024

May 09, 2024

BUY
$37.88 - $43.77 $109,511 - $126,539
2,891 Added 197.07%
4,358 $186,000
Q4 2023

Feb 05, 2024

BUY
$31.71 - $38.95 $46,518 - $57,139
1,467 New
1,467 $56,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.